Singapore markets close in 6 hours 47 minutes

SQI Diagnostics Inc. (SQIDF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01490.0000 (0.00%)
At close: 02:06PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0149
Open0.0138
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0149 - 0.0149
52-week range0.0093 - 0.0607
Volume129,902
Avg. volume0
Market cap6.067M
Beta (5Y monthly)-0.37
PE ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings date28 May 2024 - 03 Jun 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • CNW Group

    SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing

    SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF) today announced that the Company's board of directors (the "Board") has received a notice of intention (the "Notice") to enforce security issued by its senior secured creditor, Pivot Financial I Limited Partnership ("Pivot"), under Section 244(1) of the Bankruptcy and Insolvency Act (the "Act").

  • CNW Group

    SQI Diagnostics Reports Internal Restructuring

    SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today announced that the Company's board of directors (the "Board") has issued layoff notices to each of Andrew Morris, the Company's Chief Executive, and Eric Brouwer, the Company's Chief Scientific Officer, in an effort to further reduce the Company's expenses. Messrs. Morris and Brouwer have advised the

  • CNW Group

    SQI Diagnostics Reports Second Quarter 2023 Results

    SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported its financial and operational results for the second quarter ended March 31, 2022.